Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Crossover Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy Participants Under Fasting Conditions

NCT07804303 is registered in ClinicalTrials.gov with Shanghai Xin Huanghe Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07804303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Crossover Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy Participants Under Fasting Conditions
Lead sponsor
Shanghai Xin Huanghe Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
January 13, 2024
Completion date
January 24, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic obstructive pulmonary disease (copd)